EUVIMEDEUVIMED entdecken
Crossref

Natural drug-derived carbon dots as a novel oral dosing strategy for gouty arthritis

Ying Zhang, Jinyu Ma, Peng Zou, Minlong Xia, Siqi Wang, Bilin Jin, Zixuan Lu, Changming Zhai, Herui Huang, Yue Zhang, Hui Kong, Huihua Qu und 1 weitere

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2025.115805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Ying Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Dongfang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China. Hauptthemen laut MEDLINE: Arthritis, Gouty, Carbon, Biological Products, Anti-Inflammatory Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Taishan Industry Leading Talents, Fundamental Research Funds for the Central Universities, Beijing University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Gouty arthritis (GA), an acute inflammatory disorder triggered by monosodium urate (MSU) crystal deposition, poses a significant global health challenge due to rising prevalence and limitations of current therapies, including single-target mechanisms and adverse effects. The newly synthesized carbon dots (CDs) via high-temperature processing exhibit improved therapeutic efficacy and reduced toxicity. METHODS: Aconitum Lateralis Radix Praeparata Carbonis-derived Carbon Dots (ALRPC-CDs) were synthesized through a high-temperature carbonization method (400 °C) and characterized by transmission electron microscopy (TEM), high-resolution TEM (HRTEM), ultraviolet-visible (UV-Vis) spectroscopy, fluorescence (FL) spectroscopy, Fourier-transform infrared (FTIR) spectroscopy, X-ray photoelectron spectroscopy (XPS), X-ray diffraction (XRD), and high-performance liquid chromatography (HPLC). Pharmacodynamic assessments included hot-plate analgesia tests, xylene-induced ear edema assays, monosodium urate (MSU)-induced gouty arthritis models, and oxonate potassium/hypoxanthine-induced hyperuricemic models. Biocompatibility was systematically evaluated in LO2 hepatocytes and 293 T renal cells using cell counting kit-8 (CCK-8) assays. RESULTS: ALRPC-CDs exhibited monodisperse spherical morphology (1.78 ± 0.42 nm) with graphitic lattice structures (d-spacing 0.212 nm), displaying excitation/emission maxima at 314/417 nm. Pharmacodynamic studies revealed their multi-mechanistic therapeutic effects, including robust suppression of the TLR2/4-MyD88-NF-κB pathway, inhibition of xanthine oxidase activity, and significant urate-lowering effects, alongside anti-inflammatory, analgesic, and anti-hyperuricemic activity comparable to clinical controls. Biocompatibility was confirmed with excellent safety profiles. CONCLUSION: This study demonstrates that ALRPC-CDs alleviate gouty arthritis through dual suppression of inflammatory signaling (TLR2/4-MyD88-NF-κB) and uric acid metabolism (xanthine oxidase inhibition), bridging herbal medicine and nanotechnology for multi-target therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, GoutyCarbonBiological ProductsAnti-Inflammatory AgentsQuantum DotsAnimalsHumansUric AcidMaleMiceAdministration, OralHyperuricemiaHEK293 CellsRats

Stichwörter der Autor:innen

ALRPC-CDs pharmacological mechanismCarbon dotsGouty arthritisHyperuricemiaNatural medicineTLR2/4-MyD88-NF-κB pathway

Substanzen

Uric AcidCarbonBiological ProductsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Dongfang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China.
  • School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
  • Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, China.
  • School of Life Science, Beijing University of Chinese Medicine, Beijing 100029, China.
  • Centre of Scientific Experiment, Beijing University of Chinese Medicine, Beijing 100029, China.

Förderung

  • Taishan Industry Leading Talents
  • Fundamental Research Funds for the Central Universities
  • Beijing University of Chinese Medicine

Zitieren

APA

Zhang, Y., Ma, J., Zou, P., Xia, M., Wang, S., Jin, B., Lu, Z., Zhai, C., Huang, H., Zhang, Y., Kong, H., Qu, H., & Zhao, Y. (2026). Natural drug-derived carbon dots as a novel oral dosing strategy for gouty arthritis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115805

Vancouver

Zhang Y, Ma J, Zou P, Xia M, Wang S, Jin B, et al. Natural drug-derived carbon dots as a novel oral dosing strategy for gouty arthritis. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2025.115805

BibTeX
@article{Zhang2026,
  author = {Zhang, Ying and Ma, Jinyu and Zou, Peng and Xia, Minlong and Wang, Siqi and Jin, Bilin and Lu, Zixuan and Zhai, Changming and Huang, Herui and Zhang, Yue and Kong, Hui and Qu, Huihua and Zhao, Yan},
  title = {Natural drug-derived carbon dots as a novel oral dosing strategy for gouty arthritis},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2025.115805}
}
Kostenlos starten →